Hrt Financial LP Acumen Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.97 - $4.64 $312,197 - $487,742	105,117 New	105,117 $425,000
Q1 2023 May 12, 2023	BUY	$3.75 - $6.65 $84,161 - $149,245	22,443 Added 108.57%	43,115 $175,000
Q4 2022 Feb 10, 2023	BUY	$4.81 - $10.17 $99,432 - $210,234	20,672 New	20,672 $111,000
Q1 2022 May 16, 2022	SELL	$3.91 - $6.73 $320,295 - $551,301	-81,917 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.54 - $15.31 $535,737 - $1.25 Million	81,917 New	81,917 $553,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $79.8M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.